CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) has been given an average rating of “Hold” by the six analysts that are covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $117.00.
CHEOY has been the subject of several research reports. UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Jefferies Financial Group lowered CochLear to a “hold” rating in a report on Wednesday. Finally, Royal Bank Of Canada cut CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price on the stock. in a research report on Thursday, July 16th.
View Our Latest Stock Analysis on CHEOY
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Articles
- Five stocks we like better than CochLear
- Archer and Anduril Put ACHR Stock on a New Defense Flight Path
- PayPal Rejected a $53 Billion Takeover Bid: Is the Stock Undervalued?
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
